| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular Biology (Y.H., G.R.S.) Research
Institute The Cleveland Clinic Foundation Cleveland, Ohio
44195
Imperial Cancer Research Fund (D.W., N.C.R.)
Lincolns Inn Fields London WC2A 3PX, UK
Several different Janus kinases (JAKs) and signal transducers and activation of transcription (STATs) have been implicated in mediating the biological responses induced by PRL, based on their ligand-dependent tyrosine phosphorylation and activation. However, these criteria alone do not prove that a particular JAK or STAT is essential for signal transduction. We have used mutant cell lines defective in JAK1, JAK2, or STAT1 to examine their roles in PRL-dependent signaling. JAK2 is absolutely required for PRL-dependent phosphorylation of the receptor, activation of STATs, and induction of ß-lactoglobulin. Wild type, but not kinase-negative JAK2, restores all responses to PRL in JAK2-defective cells, suggesting that JAK2 function, not merely the protein, is required. In contrast, JAK1, which is phosphorylated in response to PRL, is not required for any of these functions. Although STAT1 homodimers do form in response to PRL, no defect in PRL-dependent signaling is apparent when STAT1 is missing, suggesting that STAT5, which is strongly activated in response to PRL, is primarily responsible for driving the expression of PRL-responsive genes.
This article has been cited by other articles:
![]() |
L. Qian, V. Lopez, Y. A. Seo, and S. L. Kelleher Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells Am J Physiol Cell Physiol, August 1, 2009; 297(2): C369 - C377. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, J. F. Langenheim, X. Wang, J. Jiang, W. Y. Chen, and S. J. Frank Activation of Growth Hormone Receptors by Growth Hormone and Growth Hormone Antagonist Dimers: Insights into Receptor Triggering Mol. Endocrinol., April 1, 2008; 22(4): 978 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Neilson, J. Zhu, J. Xie, M. G. Malabarba, K. Sakamoto, K.-U. Wagner, R. A. Kirken, and H. Rui Coactivation of Janus Tyrosine Kinase (Jak)1 Positively Modulates Prolactin-Jak2 Signaling in Breast Cancer: Recruitment of ERK and Signal Transducer and Activator of Transcription (Stat)3 and Enhancement of Akt and Stat5a/b Pathways Mol. Endocrinol., September 1, 2007; 21(9): 2218 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Litterst, S. Kliem, D. Marilley, and E. Pfitzner NCoA-1/SRC-1 Is an Essential Coactivator of STAT5 That Binds to the FDL Motif in the {alpha}-Helical Region of the STAT5 Transactivation Domain J. Biol. Chem., November 14, 2003; 278(46): 45340 - 45351. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hou, S. Srivastava, M. J. Mistry, M. P. Herbst, J. P. Bailey, and N. D. Horseman Two Tandemly Linked Interferon-{gamma}-Activated Sequence Elements in the Promoter of Glycosylation-Dependent Cell Adhesion Molecule 1 Gene Synergistically Respond to Prolactin in Mouse Mammary Epithelial Cells Mol. Endocrinol., October 1, 2003; 17(10): 1910 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frasor, U. Barkai, L. Zhong, A. T. Fazleabas, and G. Gibori PRL-Induced ER{alpha} Gene Expression Is Mediated by Janus Kinase 2 (Jak2) While Signal Transducer and Activator of Transcription 5b (Stat5b) Phosphorylation Involves Jak2 and a Second Tyrosine Kinase Mol. Endocrinol., November 1, 2001; 15(11): 1941 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
C V Clevenger and J B Kline Prolactin receptor signal transduction Lupus, October 1, 2001; 10(10): 706 - 718. [Abstract] [PDF] |
||||
![]() |
A. Prigent-Tessier, U. Barkai, C. Tessier, H. Cohen, and G. Gibori Characterization of a Rat Uterine Cell Line, UIII Cells: Prolactin (PRL) Expression and Endogenous Regulation of PRL-Dependent Genes; Estrogen Receptor {{beta}}, {{alpha}}2-Macroglobulin, and Decidual PRL Involving the Jak2 and Stat5 Pathway Endocrinology, March 1, 2001; 142(3): 1242 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. S. Rani, D. W. Leaman, Y. Han, S. Leung, E. Croze, E. N. Fish, A. Wolfman, and R. M. Ransohoff Catalytically Active TYK2 Is Essential for Interferon-beta -mediated Phosphorylation of STAT3 and Interferon-alpha Receptor-1 (IFNAR-1) but Not for Activation of Phosphoinositol 3-Kinase J. Biol. Chem., November 5, 1999; 274(45): 32507 - 32511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Kazansky, E. B. Kabotyanski, S. L. Wyszomierski, M. A. Mancini, and J. M. Rosen Differential Effects of Prolactin and src/abl Kinases on the Nuclear Translocation of STAT5B and STAT5A J. Biol. Chem., August 6, 1999; 274(32): 22484 - 22492. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text] |
||||
![]() |
M. Kanzaki and P. L. Morris Lactogenic Hormone-Inducible Phosphorylation and Gamma-Activated Site-Binding Activities of Stat5b in Primary Rat Leydig Cells and MA-10 Mouse Leydig Tumor Cells Endocrinology, April 1, 1998; 139(4): 1872 - 1882. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |